BioSpace News Archive

Considerations and challenges in inhalation toxicology to include small molecules, proteins, peptides and gene therapy aerosol delivery

New data released by the Canadian Institute for Health Information shows that emergency department visits dropped by 25% in March 2020, compared with March 2019.

The demand in the global medical imaging software market is expected to expand at a notable CAGR during the forecast period of 2017 to 2025.

In recent years, considerable progress has been made in life science research. As an interdisciplinary field, bioinformatics services combines computer science, statistics and life sciences together in the form of algorithms.

ASLAN Pharmaceuticals announced the resumption of patient recruitment into its randomised, double-blind, placebo-controlled multiple ascending dose study of ASLAN004 in moderate to severe atopic dermatitis.

Opthea Limited announces that it has confidentially submitted a draft registration statement on Form F-1 to the U.S. SEC relating to a potential initial public offering of American Depositary Shares in the U.S. representing Opthea’s ordinary shares, which will remain listed on the Australian Securities Exchange, and concurrent listing of the ADSs on the Nasdaq Stock Market.

The board of directors of Medtronic plc on Friday, August 21, 2020, approved the fiscal year 2021 second quarter cash dividend of $0.58 per ordinary share, representing a 7 percent increase over the prior year.

NovaBay® Pharmaceuticals, Inc. announces the appointment of President and CEO Justin Hall to the Company’s board of directors, effective August 21, 2020.

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that Dr. David Stein has been appointed as its new Chairman of the Board. Dr. Stein, along with members of the PixCell Medical Board of Directors,

Lumiata announced FGC Health, based out of Winnipeg, Manitoba, Canada, has signed a contract to use Lumiata’s artificial intelligence predictive models to identify high-risk patients.